Levofree (Levocabastine)

Levocabastine is a selective histamine H1‑receptor antagonist. By binding to H1 receptors on conjunctival mast cells and sensory nerves, it blocks histamine‑mediated vasodilation and nerve activation, which diminishes the inflammatory signs of ocular allergy.

The specific dosing regimen is determined by the prescribing clinician. Typically, one drop is instilled into the affected eye(s) as needed, but the exact frequency and duration should follow the prescriber’s instructions.

Safety data for levocabastine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the Levofree product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levofree (levocabastine) offers rapid onset of action and a well‑characterised safety profile. Compared with agents such as olopatadine, levocabastine may cause slightly more transient stinging but is similarly effective in controlling itching and redness. Choice often depends on clinician preference and patient tolerance.

Levofree should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from direct light and moisture, and avoid freezing. Do not use the product after the expiration date printed on the label.

Levofree is applied topically to the eye. The patient should wash hands, tilt the head back, pull down the lower eyelid, and place a single drop into the conjunctival sac. Close the eye gently for a few seconds and avoid blinking excessively to allow absorption.

While uncommon, serious adverse events can include severe allergic reactions such as anaphylaxis, corneal ulceration, significant visual loss, or persistent ocular inflammation. Patients should seek immediate medical attention if they experience swelling of the eyelids, intense pain, or sudden vision changes.

Levofree should be avoided in individuals with a known hypersensitivity to levocabastine or any component of the formulation. It is also contraindicated in patients who have experienced severe ocular reactions to other antihistamine eye drops.